HEC Forum

, Volume 24, Issue 4, pp 293–305 | Cite as

The Eroding Principle of Justice in Teaching Medical Professionalism



This article examines the difficulties encountered in teaching professionalism to medical students in the current social and political climate where economic considerations take top priority in health care decision making. The conflict between the commitment to advocate at all times the interests of one’s patients over one’s own interests is discussed. With personal, institutional, tech industry, pharmaceutical industry, and third-party payer financial imperatives that stand between patients and the delivery of health care, this article investigates how medical ethics instructors are to teach professionalism in a responsible way that does not avoid dealing with the principle of justice.


Medical professionalism Social justice Medical students Teaching professionalism 


  1. AAMC. (1998). Report I Learning Objectives for Medical Student Education-Guidelines for Medical Schools. Washington, DC: Association of American Medical Colleges.Google Scholar
  2. Aaron, H. J. (2003). The Costs of Health Care Administration in the United States and Canada—Questionable Answers to a Questionable Question. New England Journal of Medicine, 349(8), 801–803.CrossRefGoogle Scholar
  3. American Board of Internal Medicine. (2008). Project Professionalism, 1999 (revised). In R. L. Cruess, S. R. Cruess, & Y. Steinert (Eds.), Teaching medical professionalism (p. 282). Cambridge: Cambridge University Press.Google Scholar
  4. Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.Google Scholar
  5. Associated Press. (2001, April 12). Doctor charged in fraud case. New York Times. Sect C: 16.Google Scholar
  6. Beauchamp, T. L., & Childress, J. F. (2008). Principles of biomedical ethics (6th ed.). New York: Oxford University Press.Google Scholar
  7. Bogardus, S. T., Geist, D. E., & Bradley, E. H. (2004). Physicians’ interactions with third-party payers is deception necessary? Archives of Internal Medicine, 164, 1841–1844.CrossRefGoogle Scholar
  8. Bryan, C. S. (1994). What is the Oslerian tradition? Annals of Internal Medicine, 120(8), 682–687.Google Scholar
  9. Central Intelligence Agency, “The World Factbook: Country Comparison—Life Expectancy at Birth”. (2012). Accessed August 3, 2012 from https://www.cia.gov/library/publications//the-world-factbook/rankorder/2102rank.html?countryName=Northern%20Mariana%20Islands&countryCode=cq&regionCode=au&rank=65#cq.
  10. Chen, P. W. (2011, July 28). The hidden costs of medical student debt. New York Times. Accessed February 1, 2012 from http://well.blogs.nytimes.com/2011/07/28/the-hidden-costs-of-medical-student-debt/.
  11. Congressional Budget Office. (2008). Technological change and the growth of health care spending. Washington, DC: CBO.Google Scholar
  12. Coontz, S. (2000). The way we never were: American families and the nostalgia trap. New York: Basic Books.Google Scholar
  13. Courtwright, D. T. (1982). Dark paradise: Opiate addiction in America before 1940. Cambridge, MA: Harvard University Press.Google Scholar
  14. Cutler, D. (2005). Your money or your life: Strong medicine for america’s health care system. Oxford: Oxford University Press.Google Scholar
  15. DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003). The price of innovation: New estimates of drug development costs. Journal of Health Economics, 22, 151–185.CrossRefGoogle Scholar
  16. Dorsey, E. R., Jarjoura, D., & Rutecki, G. W. (2003). Influence of controllable lifestyle on recent trends in specialty choice by us medical students. JAMA, 290(9), 1173–1174.CrossRefGoogle Scholar
  17. Editorial. (2005, December 20). Bayhing for blood or doling out cash? A landmark law has allowed American universities to profit by patenting their innovations but the costs are adding up, The Economist, p. 109.Google Scholar
  18. Fritsch, J. (2001, October 16). Doctor sentenced for insurance fraud. New York Times, Sect D: 3.Google Scholar
  19. Goodman, J., McElligot, A., & Marks, L. (Eds.). (2003). Useful bodies: Humans in the service of medical science in the twentieth century. Baltimore: Johns Hopkins University Press.Google Scholar
  20. Graham, D. (2000). Revisiting hippocrates: Does an oath really matter. JAMA, 284(22), 2841–2842.CrossRefGoogle Scholar
  21. Greysen, S. R., Chen, C., & Mullan, F. (2011). A history of medical student debt: Observations and implications for the future of medical education. Academic Medicine, 86(7), 840–845.CrossRefGoogle Scholar
  22. Irish, D. P., & McMurray, D. W. (1995). Professional oaths and American medical colleges. Journal of Chronic Diseases , 18, 275–289.CrossRefGoogle Scholar
  23. Jackson, J. (1991). Telling the truth. Journal of Medical Ethics, 17, 5–9.CrossRefGoogle Scholar
  24. Kandall, S. R. (1996). Substance and shadow: Women and addiction in the United States. Cambridge, MA: Harvard University Press.Google Scholar
  25. Kassebaum, D. G., Szenas, P. L., & Schuchert, M. K. (1996). On rising medical student debt: In for a penny, in for a pound. Academic Medicine, 71(10), 1124–1134.CrossRefGoogle Scholar
  26. Kirch, D. G., & Vernon, D. J. (2009). The ethical foundation of American medicine: In search of social justice. JAMA, 301(14), 1482–1484.CrossRefGoogle Scholar
  27. Kreier, R. (1995, September 11). Anesthesiologists Sue Aetna: Made us skimp quality. AMA News, p. 4.Google Scholar
  28. Lederer, S. (1995). Subjected to science: Human experimentation in America before the second world war. Baltimore: Johns Hopkins University Press.Google Scholar
  29. Lee, J. (1995, August 22). Doctors Sue HMO; Cite decisions in patient care. USA Today.Google Scholar
  30. Light, D. W., & Warburton, R. (2011). Demythologizing the high costs of pharmaceutical research. BioSocieties. Accessed January 10, 2012 from http://www.pharmamyths.net/files/Biosocieties_2011_Myths_of_High_Drug_Research_Costs.pdf.
  31. Loise, V., & Stevens, A. J. (2010). The Bayh-Dole Act turns 30. Science and Translational Medicine, 2(52), cm27.Google Scholar
  32. Meister, R. (2011). They pledged your tuition: An open letter to UC students. Berkeley, CA: The Council of UC Faculty Associations. Accessed January 5, 2012 from http://www.cucfa.org/news/tuition_bonds.php.
  33. Norbut, M. (2004). Set a policy about extra exams in a single appointment. American Medical News, 47(48), 23.Google Scholar
  34. Peden, E. A., & Freeland, M. S. (1998). Insurance effects on US medical spending (1960–1993). Health Economics, 7(8), 671–687.CrossRefGoogle Scholar
  35. Pimple, K. D. (2001). Is it ethical to lie to secure hospital admission? No: Lying undermines the practice of medicine. Western Journal of Medicine, 175, 221.CrossRefGoogle Scholar
  36. Pub. L. No. 89–329 (1965). The law was reauthorized in 1968, 1971, 1972, 1976, 1980, 1986, 1992, 1998, and 2008.Google Scholar
  37. Rawls, J. (1971). A theory of justice. Cambridge, MA: Belknap Press of Harvard University Press.Google Scholar
  38. Raynor, M. E., & Panetta, J. A. (2005). A better way to R&D? Harvard Business Review, Strategy & Innovation Newsletter, 3(2), 15. Accessed January 19, 2012 from http://blogs.hbr.org/hmu/2008/02/a-better-way-to-rd.html.
  39. Relman, A. S. (1998). Education to defend professional values in the new corporate age. Academic Medicine, 73, 1229–1233.CrossRefGoogle Scholar
  40. Rosenberg, P. (2011). Pepper spray nation: With most of the UC board of regents being in the 1 %, student demonstrators should expect more police brutality. Al Jazeera English. Accessed December 3, 2011 fromhttp://www.aljazeera.com/indepth/opinion/2011/11/20111124103714508499.html.
  41. Schlesinger, M. (2004). The danger of the market panacea. In L. D. Brown, L. Jacobs, & J. Morone (Eds.), Healthy, wealthy and fair: Health care for a good society. Oxford: Oxford University Press.Google Scholar
  42. Schuller, D. E. (1996). The ‘business’ of medicine: Hippocratic or hypocritical? Annals of Allergy, Asthma & Immunology, 77, 28–32.CrossRefGoogle Scholar
  43. Sharife, K. (2011). The great billion dollar drug scam: A series examining methods used by multinational drug corporations to control markets and lives. Al Jazeera English. Accessed July 18, 2011 from http://www.aljazeera.com/indepth/opinion/2011/06/20116297573191484.html.
  44. Smith, L. (2008). A brief history of medicine’s hippocratic oath, or how times have changed. Otolaryngology—Head and Neck Surgery, 139, 1–4.CrossRefGoogle Scholar
  45. Starr, P. (1984). The social transformation of american medicine: The rise of a sovereign profession and the making of a vast industry. New York: Basic Books.Google Scholar
  46. Swick, H. M. (1998). Academic medicine must deal with the clash of business and professional values. Academic Medicine, 73, 751–755.CrossRefGoogle Scholar
  47. Swick, H. M. (2000). Toward a normative definition of medical professionalism. Academic Medicine, 75, 612–616.CrossRefGoogle Scholar
  48. United Nations, Department of Economic and Social Affairs, Population Division, World Population Prospects, the 2010 Revision (updated 28 June 2011). Accessed July 24, 2012 from http://esa.un.org/unpd/wpp/Excel-Data/mortality.htm.
  49. University of California. (2010). University of California Annual Report on Major Capital Improvement Projects Fiscal Year 2008–09. Budget and Capital Resources, University of California Office of the President, p. 3. Accessed January 30, 2012 from http://www.ucop.edu/facil/pd/documents/majorcap0809.pdf.

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  1. 1.Institute for the Medical HumanitiesUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations